[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:hepatitis-b-virus-surface-antibody":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Hepatitis B Virus Surface Antibody",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04588077","Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis",[11],"Phase 4","RECRUITING","2026-08-26T02:17:11.311767Z","2026-05-05T02:43:27.918762Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT07449091","Adaptability of an Undetectable = Untransmissible Model for HBV",[],"2026-08-26T02:17:20.511551Z","2026-05-13T02:55:06.705617Z"]